Induced Resistance in Leukaemia L1210 to Adriamycin and Its Cross-Resistance to Vincristine and Bouvardin
Authors:
- M.P. ChitnisMCM.P. Chitnis
- S.S. JoshiSJS.S. Joshi
- R.P. GudeRGR.P. Gude
- R.S. MenonRMR.S. Menon
- 1 January 1982
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 28 (3) , 209-212
Abstract
The induction of complete resistance to adriamycin in L1210 leukaemia was accomplished after 10 transplant generations. The adriamycin-resistant subline showed cross-resistance to vincristine and bouvardin. It was sensitive to methotrexate; this was observed by a 50% increase in life span compared to the life span of untreated control animals.Keywords
This publication has 8 references indexed in Scilit:
- Current results of the screening program at the division of cancer treatment, national cancer institute1981
- Effect of Bouvardin (NSC 259968) on the Growth Characteristics and Nucleic Acids and Protein Syntheses Profiles of P388 Leukemia CellsChemotherapy, 1981
- Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemiaCancer Letters, 1979
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- Biochemical Parameters of Resistance of an Adriamycin-Resistant Subline of P388 Leukemia to Emetine, an Inhibitor of Protein SynthesisJNCI: Journal of the National Cancer Institute, 1978
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978
- Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemiaBritish Journal of Cancer, 1976
- ACTIVITY OF ANTHRACYCLINES AGAINST AN ADRIAMYCIN (NSC-123127)-RESISTANT SUBLINE OF P388 LEUKEMIA WITH SPECIAL EMPHASIS ON CINERUBIN-A (NSC-18334)1976